Smilegate's Crossfire holds a curious place in shooter history. The free-to-play tactical shooter, which dominated Asian markets for over a decade, shares its name with another singleplayer campaign that predates it by years. Remedy Entertainment developed the original Crossfire in 2010, a now-obscure narrative-driven shooter that launched on PC.
Remedy's Crossfire arrived during the Finnish studio's transition between major franchises. The game followed their work on Alan Wake and preceded Quantum Break. It operated as a straightforward, Korea-inspired tactical experience distinct from Remedy's typical action-heavy design philosophy. The title never achieved mainstream traction in Western markets, and it has largely vanished from gaming consciousness.
Smilegate's 2007 launch of their own Crossfire IP created an awkward nomenclature situation. The Korean studio built a global phenomenon, particularly in Asia and China, where the game sustained millions of concurrent players across PC cafes. Its tactical team-based gameplay drew comparisons to Counter-Strike, which influenced its market positioning. Smilegate maintained Crossfire's relevance through consistent content updates, seasonal events, and competitive esports support.
The naming overlap reflects how the gaming industry handles IP territories and market segmentation. Remedy's Crossfire operated almost entirely outside Asia, making coexistence viable in practical terms. However, the obscurity of Remedy's version meant most players worldwide know only Smilegate's iteration.
Remedy has since moved on to bigger franchises and studio-defining projects. Their recent output includes Control and the upcoming Alan Wake 2, which secured critical acclaim. Smilegate continues supporting Crossfire aggressively, though the franchise faces pressure from newer tactical shooters and declining PC cafe relevance in modernizing markets.
The situation illustrates how niche regional releases can vanish from